Community news

Last Tuesday, together with SmiLe Venture Hub, we organised Module 5 of our accelerator programme, 10XHealth. C-level leaders from our seven participating companies joined us to explore Regulatory Strategy and Commercialisation, expertly guided by Thomas Camnell and Jeanette Demorney from GBA Key2Compliance, Jenny Strömberg and Georg Marthin from Business Sweden, …

We warmly welcome Carpenova Nordic as a new member of our life science park, located in The Spark building. Carpenova Nordic is an executive search firm specialising in identifying and recruiting leaders, managers and key specialists across the Nordic region. With industry expertise in areas such as life science, automotive, …

Gedea Biotech today announces a planned CEO transition. After close to ten years as CEO, Annette Säfholm has decided to step down from her role. The Board of Directors has appointed Julie Waras Brogren as the new Chief Executive Officer. Julie has more than 20 years of experience from the …

On 26 January, a well-attended conference was held at Skåne University Hospital (SUS) in Lund to highlight how the establishment of a regional data lake strengthens the conditions for research and development. The conference formed part of the EU-funded project “Datasjö för att stärka Skånes Life Science-industri” (Data Lake to …

On 23 January, Lund University’s Annual Academic Ceremony was celebrated with a solemn event in a fully packed University Hall in central Lund. The ceremony marks the anniversary of the University’s inauguration in 1668 and is an opportunity to recognise outstanding research, special achievements and distinguished contributions connected to the …

Pharmaceutical company AcuCort AB (publ) (AcuCort) has entered into a commercial agreement with the global pharmaceutical company, Glenmark Pharmaceuticals Limited (Glenmark) regarding the marketing and distribution of AcuCort’s product, Zeqmelit®, in six European countries: Germany, the Netherlands, the Czech Republic, Austria, Slovakia, and Ukraine. The commercial agreement replaces the Letter …

Lund, Sweden, January 22, 2026 Gedea Biotech today announced that the clinical trial BV2025 has started, following approval from the Swedish Medical Products Agency (Läkemedelsverket) for the treatment of bacterial vaginosis. In addition to fulfilling post-approval requirements, the results from BV2025 will also generate valuable data for the European market …

The Medical Device Coordination Group (MDCG) has published guidance MDCG 2025-9 to streamline the pathway for breakthrough devices (BtX) under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). This guidance aims to facilitate timely patient access to innovative technologies without compromising safety and performance requirements. It …

The Life Science Barometer 2026 has now been published, offering an up-to-date, data-driven snapshot of developments in the Swedish life science sector. The annual report takes the pulse of the industry by complementing official statistics with insights from company leaders across the country, providing valuable input for both business and …

We warmly welcome Fredersen Advokatbyrå as a new member of our life science park, located in our coworking space in The Spark! Fredersen offers qualified legal advice to companies, listed as well as unlisted, from offices in Malmö and Stockholm. We asked Ida Nordehammar, Business Development/Associate at Fredersen, to …

The recipients of the 2025 donations from Medicon Village’s owner, the Mats Paulsson Foundation for Research, Innovation and Societal Development, are now being showcased at Inspira. In 2025, a total of SEK 19 million was awarded to life science projects in Skåne, ranging from advanced cancer …

Interest in Medicon Village’s professional networks continues to grow, with hundreds of professionals engaging every month. Building on this momentum, we are pleased to launch the Medicon Village Sustainability Reporting Network – a new meeting place for professionals who work with sustainability reporting and related challenges. The network is …